Active substance
Nicotine
- SFDA 9
- US FDA 8
- US price lines 31
- NHS prices 28
- Safety 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Lexcotinz | 2 mg | Lozenge · Oral use | 24 Bottle | SAR 16.30 | Generic · Prescription | Aurobindo Pharma Limited | Valid |
| NICOTINELL TTS-10 | 17.5 mg | Transdermal patch · Topical | 7 Box | SAR 66.10 | NCE · OTC | Haleon Schweiz AG | Valid |
| NICOTINELL TTS-20 | 35 mg | Transdermal patch · Topical | 7 Box | SAR 66.10 | NCE · OTC | Haleon Schweiz AG | Valid |
| NICOTINELL TTS-30 | 52.5 mg | Transdermal patch · Topical | 7 Box | SAR 66.10 | NCE · OTC | Haleon Schweiz AG | Valid |
| Nicorette | 25 mg | Transdermal patch · Transdermal use | 7 Patch | SAR 60.10 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| Nicorette | 15 mg | Transdermal patch · Transdermal use | 7 Patch | SAR 60.10 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| Nicorette | 10 mg | Transdermal patch · Transdermal use | 7 Patch | SAR 60.10 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| Nicorette Freshmint Gum | 4 mg | Medicated chewing-gum · Oral use | 30 Blister | SAR 36.45 | NCE · OTC | McNeil Sweden AB | Valid |
| Nicorette Freshmint Gum | 2 mg | Medicated chewing-gum · Oral use | 30 Blister | SAR 28.30 | NCE · OTC | McNeil Sweden AB | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NICODERM CQ | 21MG/24HR; 14MG/24HR; 7MG/24HR | film, extended release · transdermal | CHATTEM SANOFI | Over-the-counter | 7 Nov 1991 |
| HABITROL | 7MG/24HR; 14MG/24HR; 21MG/24HR | film, extended release · transdermal | DR REDDYS LABS SA | Over-the-counter | 27 Nov 1991 |
| NICOTROL | 0.5MG/SPRAY | spray, metered · nasal | PFIZER INC | Prescription | 22 Mar 1996 |
| NICOTINE | 21MG/24HR; 7MG/24HR; 14MG/24HR | film, extended release · transdermal | DIFGEN PHARMS | Over-the-counter | 20 Oct 1997 |
| HABITROL | 7MG/24HR; 14MG/24HR; 21MG/24HR | film, extended release · transdermal | DR REDDYS LABS SA | Discontinued | 27 Nov 1991 |
| PROSTEP | 11MG/24HR; 22MG/24HR | film, extended release · transdermal | AVEVA | Discontinued | 28 Jan 1992 |
| NICOTROL | 15MG/16HR | film, extended release · transdermal | MCNEIL CONS | Discontinued | 3 Jul 1996 |
| NICOTROL | 4MG/CARTRIDGE | inhalant · oral | PFIZER | Discontinued | 2 May 1997 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FT NICOTINE 14 MG/24HR PATCH | $1.85466 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 2 MG CHEWING GUM | $0.23281 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 2 MG LOZENGE | $0.34675 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 2 MG MINI LOZENGE | $0.3742 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 21 MG/24HR PATCH | $1.87251 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 4 MG CHEWING GUM | $0.28661 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 4 MG LOZENGE | $0.34431 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 4 MG MINI LOZENGE | $0.38851 | per EA | 23 Sep 2026 |
| US NADAC | FT NICOTINE 7 MG/24HR PATCH | $1.81971 | per EA | 23 Sep 2026 |
| US NADAC | GNP NICOTINE 2 MG CHEWING GUM | $0.23281 | per EA | 23 Sep 2026 |
| US NADAC | GNP NICOTINE 2 MG LOZENGE | $0.34675 | per EA | 23 Sep 2026 |
| US NADAC | GNP NICOTINE 2 MG MINI LOZENGE | $0.3742 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Nicotine 10mg/16hours transdermal patches | £11.85 | 7 patch | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 14mg/24hours transdermal patches | £10.82 | 7 patch | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 15mg inhalation cartridges with device | £7.42 | 4 cartridge | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 15mg inhalation cartridges with device | £26.58 | 20 cartridge | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 15mg inhalation cartridges with device | £41.25 | 36 cartridge | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 15mg/16hours transdermal patches | £11.85 | 7 patch | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 1mg/dose oromucosal spray sugar free | £15.57 | 13.2 ml | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 21mg/24hours transdermal patches | £11.48 | 7 patch | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 25mg/16hours transdermal patches | £11.85 | 7 patch | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 2mg lozenges sugar free | £7.01 | 40 lozenge | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 2mg lozenges sugar free | £7.40 | 72 lozenge | 1 Oct 2026 |
| NHS Drug Tariff | Nicotine 2mg lozenges sugar free | £12.05 | 80 lozenge | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 23 May 2024 NICOTROL — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 23 May 2024 NICOTROL — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 6 Jul 2016 HABITROL — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 4 May 2016 NICODERM CQ — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.